BeOne Medicines AG Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	2,558	4,548	2,627	3,172	3,870	4,376
Short-Term Investments	-	-	-	-	665.25	2,245
Cash & Short-Term Investments	4,847	4,548	2,627	3,172	4,535	6,621
Cash Growth	92.63%	73.08%	-17.16%	-30.06%	-31.50%	42.36%
Accounts Receivable	922.28	865.08	676.28	358.03	173.17	483.11
Other Receivables	10.48	21.78	32.83	37.86	25.82	17.06
Receivables	932.76	886.86	709.11	395.89	198.98	500.18
Inventory	682.42	608.23	494.99	416.12	282.35	242.63
Prepaid Expenses	-	55.93	49.37	88.26	83.09	138.81
Restricted Cash	-	41.28	9.31	11.47	0.2	0.33
Other Current Assets	148.99	93.76	101.41	119.88	107.65	111.32
Total Current Assets	6,612	6,234	3,992	4,203	5,207	7,614
Property, Plant & Equipment	1,642	1,790	1,718	1,419	955.91	705.04
Long-Term Investments	66.13	61.68	128.93	89.64	91.78	100.79
Goodwill	-	-	-	-	-	0.11
Other Intangible Assets	177.43	62.7	51.1	57.14	40.62	46.68
Other Long-Term Assets	38.29	40.74	31.56	35.72	83.91	69.03
Total Assets	8,564	8,189	5,921	5,805	6,379	8,536
Accounts Payable	739.37	479.04	405	315.11	294.78	262.4
Accrued Expenses	151.93	961.09	780.48	624.92	480.1	534.33
Short-Term Debt	58.05	9.06	816.95	659.79	314.83	424.74
Current Portion of Long-Term Debt	117.35	48.23	34.58	28.58	14.14	2.82
Current Portion of Leases	-	20.7	17.58	21.95	24.04	21.93
Current Income Taxes Payable	158.31	41.63	25.93	22.95	25.19	21.4
Current Unearned Revenue	36.62	56.71	-	-	213.86	187.41
Other Current Liabilities	511.05	212.37	134.39	136.82	101.59	144.53
Total Current Liabilities	1,773	1,829	2,215	1,810	1,469	1,600
Long-Term Debt	965.33	961.91	166.48	197.62	209.15	202.11
Long-Term Leases	49.76	52.94	44.28	22.25	34.52	43.04
Long-Term Unearned Revenue	28.73	879.22	30.32	34.2	80.2	266.64
Pension & Post-Retirement Benefits	-	18.17	16.41	15	7.76	7.81
Long-Term Deferred Tax Liabilities	48.04	53.21	42.01	16.49	16	14.17
Other Long-Term Liabilities	910.42	33.1	74.29	172.27	179.78	269.63
Total Liabilities	3,775	3,827	2,589	2,268	1,996	2,403
Common Stock	0.14	0.14	0.14	0.14	0.14	0.13
Additional Paid-In Capital	13,301	12,759	12,088	11,599	11,541	11,191
Retained Earnings	-8,641	-8,320	-8,607	-7,962	-7,080	-5,077
Comprehensive Income & Other	128.93	-78.18	-148.99	-99.45	-77.42	17.95
Total Common Equity	4,789	4,361	3,332	3,537	4,383	6,133
Shareholders' Equity	4,789	4,361	3,332	3,537	4,383	6,133
Total Liabilities & Equity	8,564	8,189	5,921	5,805	6,379	8,536
Total Debt	1,190	1,093	1,080	930.19	596.68	694.64
Net Cash (Debt)	3,657	3,455	1,548	2,242	3,938	5,926
Net Cash Growth	140.65%	123.24%	-30.96%	-43.08%	-33.54%	44.94%
Net Cash Per Share	31.35	30.45	14.70	21.47	38.19	63.87
Filing Date Shares Outstanding	111.17	110.94	106.72	104.58	104.32	102.68
Total Common Shares Outstanding	111.11	110.85	106.72	104.58	104.32	102.68
Working Capital	4,839	4,405	1,777	2,393	3,739	6,014
Book Value Per Share	43.10	39.34	31.22	33.82	42.02	59.73
Tangible Book Value	4,612	4,298	3,281	3,480	4,343	6,086
Tangible Book Value Per Share	41.50	38.78	30.75	33.28	41.63	59.27
Land	-	71.43	65.49	65.49	65.49	65.49
Buildings	-	1,188	607.86	231.66	222.45	144.08
Machinery	-	583.24	485.14	392.21	334.59	237.79
Construction In Progress	-	127.16	654.02	740.62	293.63	186.84
Leasehold Improvements	-	76.57	64.68	60.12	53.79	50.29

Source: S&P Global Market Intelligence. Standard template. Financial Sources.